Cargando…

The Prevalence of Metabolic Syndrome in Schizophrenic Patients Using Antipsychotics

OBJECTIVE: To examine the prevalence of metabolic syndrome and its risk factors in a large group of schizophrenic patients. METHODS: Sociodemographic and treatment data were collected from medical records of 1,103 inpatients and outpatients treated for schizophrenia at Seoul National Hospital in Seo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ko, You-Kyung, Soh, Min-Ah, Kang, Shi-Hyun, Lee, Jong-Il
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766759/ https://www.ncbi.nlm.nih.gov/pubmed/24023552 http://dx.doi.org/10.9758/cpn.2013.11.2.80

Ejemplares similares

Metabolic Disturbances Independent of Body Mass in Patients with Schizophrenia Taking Atypical Antipsychotics
por: Kang, Shi Hyun, et al.
Publicado: (2015)

Thiol Disulfide Homeostasis in Schizophrenic Patients Using Atypical Antipsychotic Drugs
por: Dogan, Halef Okan, et al.
Publicado: (2018)

T75. METABOLIC SYNDROME AND HEAR RATE VARIABILITY IN SCHIZOPHRENIC INPATIENTS
por: Yoon, Bo-Hyun, et al.
Publicado: (2020)

Antipsychotic Medication in Schizophrenic Patients is Associated with Higher Risks of Developing Bone Fractures and Refractures
por: Kuo, Ching-Min, et al.
Publicado: (2020)

Evolution of symptoms with antipsychotic treatment in schizophrenic outpatients in Greece: the GRACE Study
por: Karadima, Dimitra, et al.
Publicado: (2010)

Effect of antipsychotic drugs and orthostatic hypotension on the risk of falling in schizophrenic patients
por: Ferinauli, Ferinauli, et al.
Publicado: (2021)

Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients
por: Suda, Akira, et al.
Publicado: (2018)

Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis
por: Millier, Aurelie, et al.
Publicado: (2011)

Genotype-phenotype Analysis of Paraoxonase 1 in Schizophrenic Patients Treated with Atypical Antipsychotics
por: Pavăl, Denis, et al.
Publicado: (2018)

Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review
por: García, Saínza, et al.
Publicado: (2016)

Cognitive effects of atypical antipsychotic drugs in first-episode drug-naïve schizophrenic patients
por: Wang, Juan, et al.
Publicado: (2013)

An Epidemiological Study of Concomitant Use of Chinese Medicine and Antipsychotics in Schizophrenic Patients: Implication for Herb-Drug Interaction
por: Zhang, Zhang-Jin, et al.
Publicado: (2011)

ACUTE SCHIZOPHRENIC EPISODES—ARE THEY SCHIZOPHRENIC?
por: Singh, Gurmeet, et al.
Publicado: (1981)

Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study
por: Kim, Yongmin, et al.
Publicado: (2016)

antipsychotics and metabolic syndrome
por: Jomli, R., et al.
Publicado: (2022)

Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medications
por: Jaberi, Nayyer, et al.
Publicado: (2020)

Changes in the prescription pattern of antipsychotics for schizophrenic outpatients after the implementation of a global budgeting program
por: Chiu, Hsien-Jane, et al.
Publicado: (2014)

F45. THE EFFICACY AND SAFETY OF BLONASERIN AFTER SWITCHING FROM OTHER ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIC INPATIENTS: AN OPEN-LABEL, MULTI-CENTER TRIAL
por: Yoon, Bo-Hyun, et al.
Publicado: (2018)

F226. CLINICAL FACTORS ASSOCIATED WITH CONTINUATION OF LONG-ACTING INJECTABLE ANTIPSYCHOTIC MEDICATION: RETROSPECTIVE CHART REVIEW
por: Kang, Shi Hyun, et al.
Publicado: (2018)

The need for efficient long-term neuroleptic treatment in schizophrenic patients and the place of long acting injectable antipsychotics
por: Möller, Hans-Jurgen
Publicado: (2010)

Hospitalization rates and resource utilization of schizophrenic patients switched from oral antipsychotics to aripiprazole-depot in Germany
por: Potempa, Christoph, et al.
Publicado: (2018)

Comparative Study of the Effects of Atypical Antipsychotic Drugs on Plasma and Urine Biomarkers of Oxidative Stress in Schizophrenic Patients
por: Dietrich-Muszalska, Anna, et al.
Publicado: (2021)

Influence of the use of atypical antipsychotics in metabolic syndrome
por: Doménech-Matamoros, P
Publicado: (2020)

The Relationship of Functional Status of Cortisol, Testosterone, and Parameters of Metabolic Syndrome in Male Schizophrenics
por: Han, Yi, et al.
Publicado: (2020)

Increased serum interleukin-1β and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication
por: Schmitt, Andrea, et al.
Publicado: (2005)

The effect of verbalization strategy on wisconsin card sorting test performance in schizophrenic patients receiving classical or atypical antipsychotics
por: Rossi, Alessandro, et al.
Publicado: (2006)

PM515. The association between serotonin receptor gene polymorphisms and hyperprolactinemia in antipsychotic drug-treated schizophrenic patients
por: Ivanova, Svetlana, et al.
Publicado: (2016)

Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
por: Vaiman, Elena E., et al.
Publicado: (2021)

Anhedonia and Ambivalence in Schizophrenic Patients with Fronto-Cerebellar Metabolic Abnormalities: A Fluoro-D-Glucose Positron Emission Tomography Study
por: Park, Kyung-Min, et al.
Publicado: (2009)

Metabolic and clinical effect of alpha-lipoic acid administration in schizophrenic subjects stabilized with atypical antipsychotics: A 12-week, open-label, uncontrolled study
por: Iannuzzo, Fiammetta, et al.
Publicado: (2022)

THE STABILITY OF SYMPTOMS AND SYNDROMES IN CHRONIC SCHIZOPHRENIC PATIENTS
por: Borde, Milind, et al.
Publicado: (1992)

Increased serum brain-derived neurotrophic factor in male schizophrenic patients with metabolic syndrome
por: Lin, Chin-Chuen, et al.
Publicado: (2017)

Prevalence and associated factors of suicide among hospitalized schizophrenic patients
por: Woottiluk, Pakapan, et al.
Publicado: (2020)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
por: Jeon, Sang Won, et al.
Publicado: (2017)

Prevalence and management practice of first generation antipsychotics induced side effects among schizophrenic patients at Amanuel Mental Specialized Hospital, central Ethiopia: cross-sectional study
por: Wubeshet, Yirgalem Shewakena, et al.
Publicado: (2019)

PM416. Efficacy and tolerability of paliperidone palmitate long-acting injectable antipsychotic: off-label use in first-episode adolescent schizophrenic patients
por: Petrić, Daniela, et al.
Publicado: (2016)

Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study
por: Srisurapanont, Manit, et al.
Publicado: (2007)

The effect of antipsychotic medication and the associated hyperprolactinemia as a risk factor for periodontal diseases in schizophrenic patients: a cohort retrospective study
por: Shalaby, Rania, et al.
Publicado: (2023)

Psychopathology in children of schizophrenics
por: Shah, Sharita, et al.
Publicado: (2003)

Who ‘Speaks’ to the Schizophrenic?
por: Ramanathan, A.
Publicado: (1986)

Cannot write session to /tmp/vufind_sessions/sess_2rrihb1vjfc3mjtgn9hl7ptett